Jose A. Mazzitelli

Jose A. Mazzitelli

Auto-generated profile, based on publicly available information

Jose A. Mazzitelli

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2019 in Cell
Verified
Journal Article
Closed access
MJMary T. Joy
Mary T. Joy
EAEinor Ben Assayag
Einor Ben Assayag
DSDalia Shabashov-Stone
Dalia Shabashov-Stone
SLSigal Liraz-Zaltsman
Sigal Liraz-Zaltsman
JMJose Mazzitelli
Jose Mazzitelli
SCS. Thomas Carmichael
S. Thomas Carmichael

17 March 2022 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JMJose A. Mazzitelli
Jose A. Mazzitelli
LSLeon C. D. Smyth
Leon C. D. Smyth
KCKevin A. Cross
Kevin A. Cross
TDTaitea Dykstra
Taitea Dykstra
JSJerry Sun
Jerry Sun
JKJonathan Kipnis
Jonathan Kipnis

8 June 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCL. Caracciolo
L. Caracciolo
MMM. Marosi
M. Marosi
JMJ. Mazzitelli
J. Mazzitelli
SLS. Latifi
S. Latifi
YSY. Sano
Y. Sano
SCS. T. Carmichael
S. T. Carmichael
Treatments that stimulate neuronal excitability enhance motor performance after stroke. cAMP-response-element binding protein (CREB) is a transcription factor that plays a key role in neuronal excitability. Increasing the levels of CREB with a viral vector in a small pool of motor neurons enhances motor recovery after stroke, while blocking CREB signaling prevents stroke recovery. Silencing CREB-transfected neurons in the peri-infarct region with the hM4Di-DREADD blocks motor recovery. Reversing this inhibition allows recovery to continue, demonstrating that by manipulating the activity of CREB-transfected neurons it is possible to turn off and on stroke recovery. CREB transfection enhances remapping of injured somatosensory and motor circuits, and induces the formation of new connections within these circuits. CREB is a central molecular node in the circuit responses after stroke that lead to recovery from motor deficits.

23 November 2023 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JMJose A. Mazzitelli
Jose A. Mazzitelli
FPFadi E. Pulous
Fadi E. Pulous
LSLeon C. D. Smyth
Leon C. D. Smyth
ZKZeynep Kaya
Zeynep Kaya
JRJustin Rustenhoven
Justin Rustenhoven
MNMatthias Nahrendorf
Matthias Nahrendorf

21 April 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ILIrene L. Llorente
Irene L. Llorente
YXYuan Xie
Yuan Xie
JMJose A. Mazzitelli
Jose A. Mazzitelli
EHEmily A. Hatanaka
Emily A. Hatanaka
JCJessica Cinkornpumin
Jessica Cinkornpumin
SCS. Thomas Carmichael
S. Thomas Carmichael
A specific prorepair glial stem cell therapy promotes brain repair in vascular dementia in rodent models.

4 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
KBKia M. Barclay
Kia M. Barclay
NANora Abduljawad
Nora Abduljawad
ZCZuolin Cheng
Zuolin Cheng
MKMin Woo Kim
Min Woo Kim
LZLu Zhou
Lu Zhou
QLQingyun Li
Qingyun Li
SUMMARY: Recent single-cell RNA sequencing studies have revealed distinct microglial states in development and disease. These include proliferative region-associated microglia (PAM) in developing white matter and disease-associated microglia (DAM) prevalent in various neurodegenerative conditions. PAM and DAM share a similar core gene signature and other functional properties. However, the extent of the dynamism and plasticity of these microglial states, as well as their functional significance, remains elusive, partly due to the lack of specific tools. Here, we report the generation of an inducible Cre driver line, Clec7a-CreER T2 , designed to target PAM and DAM in the brain parenchyma. Utilizing this tool, we profile labeled cells during development and in several disease models, uncovering convergence and context-dependent differences in PAM/DAM gene expression. Through long-term tracking, we demonstrate surprising levels of plasticity in these microglial states. Lastly, we specifically depleted DAM in cuprizone-induced demyelination, revealing their roles in disease progression and recovery.